2012-04-19 07:12 HCL Noida, Indien, 18th April, 2012 – HCL Technologies Ltd. (HCL), tillkännagav idag resultatet för det kvartal som slutade 31 Mars, 2012. I detta tredje kvartal finansiella året 2012 uppnådde HCL en omsättning av 1048 miljoner US$, en ökning med 14.6% YoY och 2.5% QoQ. Detta kvartalet uppnådde HCL även milstolpen med en omsättning av 4 miljarder USD över de senaste 12 månaderna.
2011-09-20 13:40 ProQure | Entrémattor & Mattservice ProQure | Entremattor & Mattservice. Bra avslut för sommarperioden. Både omsättning och kundstock ökar. Läs även inlägg på ProQure | http://proqure.se/sv/lar-kanna-oss/nyheter/99-proqure-fortsatter-den-positiva-utvecklingen _________________
2011-06-14 10:01 ProQure | Entrémattor & Mattservice ProQure | Entrance Mats & Matting Service. Sales in May exceeded expectations. ProQure breaks the season trend. Read also this post in ProQure | http://www.proqure.se/2011/05/okad-efterfragan-forsta-kvartalet-2011/?lang=en _________________
2011-06-14 08:52 ProQure | Entrémattor & Mattservice ProQure | Entremattor & Mattservice. Försäljning i maj över förväntan. ProQure bryter säsongstrenden. Läs även inlägg på ProQure | http://www.proqure.se/2011/05/okad-efterfragan-forsta-kvartalet-2011/ _________________
2010-11-30 22:39 ProQure | Entrémattor & Mattservice ProQure | Entrance Mats & Matting Services. Customer confidence for ProQure is increasing. November's orderintake for entrance mats & matting services has already exceeded the previous month. Read also the news in ProQure | http://www.proqure.se/2010/11/vinter-i-skane-het-forfragan-pa-entremattor/?lang=en _________________
2010-07-23 10:25 AkzoNobel Akzo Nobel N.V. (AkzoNobel) today announced a revenue increase of 13 percent (5 percent positive currency translation effect) for the second quarter of 2010 and the early achievement of the 14 percent EBITDA margin target set for the end of 2011.
2010-02-18 08:52 AkzoNobel Akzo Nobel N.V. (AkzoNobel) today announced its 2009 Q4 and full-year results. The company reported 2009 revenue of €13,893 million, 10 percent below the previous year.
2009-10-27 12:14 AkzoNobel Akzo Nobel N.V (AkzoNobel) has today announced its results for the third quarter of 2009, which demonstrate that trading remains tough across all businesses, and that markets are stabilizing at lower levels of demand.
2009-01-27 11:00 A+ Science The CAFE-LLA* study prospectively examined the impact of Atorvastatin* (10 mg once daily) on central aortic pressures in hypertensive patients. The therapy did not influence central aortic pressure or hemodynamics in these patients. In other words the favourable effects of Statins on cardiovascular outcomes in hypertensive patients are independent of large-artery function and central pressures.
2008-12-11 15:30 A+ Science Results of the ACCOMPLISH* study were published December 4, 2008 in the New England Journal of Medicine. This study which is the first to compare Renin-Angiotensin-System Inhibitor- based single-pill combinations in reducing cardiovascular complications showed exceptional blood pressure control and substantial further risk reduction for the benazepril/amlodipine vs benazepril/diuretic combination.